HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison

被引：0
|
作者：
T. Koopman
M. M. Smits
M. Louwen
M. Hage
H. Boot
A. L. T. Imholz
机构：
[1] Deventer Hospital,Department of Medical Oncology
[2] Deventer Hospital,Department of Pathology
[3] The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Gastroenterology and Hepatology
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Gastric cancer; Esophageal cancer; Gastroesophageal cancer; Human epidermal growth factor 2 (HER2); Primary tumor location;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1343 / 1351
页数：8
相关论文
共 50 条
  • [21] Analysis of protein overexpression and Her2 gene amplification in gastric adenocarcinoma from Moroccan patients
    Fahmi, L.
    Fettachi, H.
    Hamdaoui, H.
    Mossafa, H.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S6 - S7
  • [22] Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma
    Nakayama, I.
    Takahari, D.
    Chin, K.
    Wakatsuki, T.
    Takamatsu, M.
    Yamamoto, N.
    Ogura, M.
    Ooki, A.
    Fukuda, K.
    Osumi, H.
    Fukuoka, S.
    Shinozaki, E.
    Yamaguchi, K.
    ESMO OPEN, 2023, 8 (04)
  • [23] HER2 Testing in Gastric and Gastroesophageal Adenocarcinomas
    Vakiani, Efsevia
    ADVANCES IN ANATOMIC PATHOLOGY, 2015, 22 (03) : 194 - 201
  • [24] The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
    Yu-ying Lei
    Jin-yu Huang
    Qiong-rui Zhao
    Nan Jiang
    Hui-mian Xu
    Zhen-ning Wang
    Hai-qing Li
    Shi-bo Zhang
    Zhe Sun
    World Journal of Surgical Oncology, 15
  • [25] The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
    Lei, Yu-ying
    Huang, Jin-yu
    Zhao, Qiong-rui
    Jiang, Nan
    Xu, Hui-mian
    Wang, Zhen-ning
    Li, Hai-qing
    Zhang, Shi-bo
    Sun, Zhe
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [26] Perspectives of HER2-targeting in gastric and esophageal cancer
    Gerson, James N.
    Skariah, Sam
    Denlinger, Crystal S.
    Astsaturov, Igor
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 531 - 540
  • [27] Prevalence of HER2 expression and its association with clinicopathological parameters in gastric and gastroesophageal junction adenocarcinoma: A 10?year experience of an academic center
    Bokhary, Rana Y.
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (06)
  • [28] HER-2/neu Gene Amplification in Relation to Expression of HER2 and HER3 Proteins in Patients With Esophageal Adenocarcinoma
    Yoon, Harry H.
    Sukov, William R.
    Shi, Qian
    Sattler, Christopher A.
    Wiktor, Anne E.
    Diasio, Robert B.
    Wu, Tsung-Teh
    Jenkins, Robert B.
    Sinicrope, Frank A.
    CANCER, 2014, 120 (03) : 415 - 424
  • [29] Somatostatin Receptor Subtype 2 A (SSTR2A) and HER2 Expression in Gastric Adenocarcinoma
    Romiti, Adriana
    Di Rocco, Roberta
    Milione, Massimo
    Ruco, Luigi
    Ziparo, Vincenzo
    Zullo, Angelo
    Duranti, Enrico
    Sarcina, Ida
    Barucca, Viola
    D'Antonio, Chiara
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2012, 32 (01) : 115 - 119
  • [30] Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma
    Nergiz, Dondu
    Alikanoglu, Arsenal Sezgin
    Suren, Dinc
    Gomceli, Ismail
    Ozturk, Banu
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (02) : 321 - 327
12345